Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Primary care physician decision making regarding referral for bariatric surgery: a national survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Dulaglutide for erectile dysfunction in type 2 diabetes

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. The antiresorptive effect of GIP, but not GLP-2, is preserved in patients with hypoparathyroidism- a randomized crossover study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) bariatric procedures lead to remission or improvement of type 2 diabetes. A weight loss-independent augmentation of postprandial insulin secretion contributes to the improvement in glycemic control after RYGB and is associated with a ∼10-fold increase in plasma concentrations of the incretin hormone glucagon-like peptide-1 (GLP-1). However, the physiologic importance of the markedly increased postprandial GLP-1 secretion after RYGB has been much debated. The effect of GLP-1 receptor blockade after RYGB has been investigated in 12 studies. The studies indicate a shift toward a more prominent role for GLP-1 in postprandial β-cell function after RYGB. The effect of GLP-1 receptor antagonism on glucose tolerance after RYGB is more complex and is associated with important methodological challenges. The postprandial GLP-1 response is less enhanced after SG compared with RYGB. However, the effect of GLP-1 receptor blockade after SG has been examined in 1 study only and needs further investigation.

OriginalsprogEngelsk
TidsskriftSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Vol/bind17
Udgave nummer7
Sider (fra-til)1383-1391
Antal sider9
ISSN1550-7289
DOI
StatusUdgivet - 1 jul. 2021

ID: 64651429